Komori
JCR Pharmaceuticals (4552) · FactUpdate to ownership percentage

Change in largest shareholder from GSK Group to Medipal

First written in FY2018-Q2. 2 of 9 entries say "Restated". Latest entry: FY2026.

9entries
10years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2018-Q2 – FY20262017: 12018: 120182019: 120192020: 020202021: 220212022: 120222023: 120232024: 020242025: 120252026: 12026
Same theme, other companies
Corporate shareholders becoming or ceasing to qualify as other affiliated companiesA theme 39 companies write about · 0 as a headwind · 4 as a tailwind

The whole theme swung hardest in 2020: 2 of 6 companies on the "Worse" side.

4 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 39 companies compared. The sentences above are computed from all 39.
Full recordFilings, disclosures and news, newest first
  1. FY2026Update to ownership percentageAnnual report

    「Medipal Holdings Corporation　29,131　23.83」

    Medipal Holdings Corporation remained the largest shareholder, with an ownership ratio of 23.83% as of 31 March 2026.
  2. FY2025Update to ownership percentageAnnual report

    「Medipal Holdings Corporation　3-1-1 Kyobashi, Chuo-ku, Tokyo　29,131　23.86」

    Medipal Holdings Corporation remained the largest shareholder, with an ownership ratio of 23.86% as of 31 March 2025.
  3. FY2023Update to ownership percentageAnnual report

    「Medipal Holdings Corporation　3-1-1 Yaesu, Chuo-ku, Tokyo　29,131　23.28」

    Medipal Holdings Corporation remained the largest shareholder, with an ownership ratio of 23.28% as of 31 March 2023.
  4. FY2023-Q2Update to ownership percentageAnnual report

    「Medipal Holdings Corporation　3-1-1 Yaesu, Chuo-ku, Tokyo　29,131　23.28」

    Medipal Holdings Corporation remained the largest shareholder, with an ownership ratio of 23.28% as of 30 September 2022.
  5. FY2022-Q2Update to ownership percentageAnnual report

    「Medipal Holdings Corporation　3-1-1 Yaesu, Chuo-ku, Tokyo　29,131　23.47」

    Medipal Holdings Corporation remained the largest shareholder, with an ownership ratio of 23.47% as of 30 September 2021.
  6. FY2021Update to ownership percentageAnnual report

    「Medipal Holdings Corporation　2-7-15 Yaesu, Chuo-ku, Tokyo　29,131　23.49」

    Medipal Holdings Corporation remained the largest shareholder, with an ownership ratio of 23.49% as of 31 March 2021.
  7. FY2020-Q2RestatedAnnual report

    「Medipal Holdings Corporation　2-7-15 Yaesu, Chuo-ku, Tokyo　7,282　23.55」

    Medipal Holdings Corporation remained the largest shareholder, with an ownership ratio of 23.55% as of 30 September 2019.
  8. FY2018RestatedAnnual report

    「As a result, the company’s largest shareholder changed from the GlaxoSmithKline Group to Medipal Holdings Corporation.」

    The company reconfirmed that Medipal Holdings Corporation had become its largest shareholder and disclosed a 23.60% ownership ratio at the end of the period.
  9. FY2018-Q2First statedAnnual report

    「As a result, the company’s largest shareholder changed from the GlaxoSmithKline Group to Medipal Holdings Corporation.」

    The transfer of shares from the GSK Group to Medipal Holdings Corporation changed the company’s largest shareholder and other affiliated company.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
JCR Pharmaceuticals's next results are scheduled for 2026-10-29. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.